+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 820 Pages
  • Global
From
Bullous Pemphigoid - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Bullous Pemphigoid - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Cancer Biomarkers Market - Trends and Forecast Till 2035 - Product Thumbnail Image

Cancer Biomarkers Market - Trends and Forecast Till 2035

  • Report
  • October 2026
  • 336 Pages
  • Global
From
Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030 - Product Thumbnail Image

Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • July 2023
  • 229 Pages
  • Global
From
Grass Pollen Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Grass Pollen Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 48 Pages
  • Global
From
Cervical Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Cervical Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Ophthalmic Pharmaceutical Drugs - Global Strategic Business Report - Product Thumbnail Image

Ophthalmic Pharmaceutical Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 386 Pages
  • Global
From
Next Generation Drug Conjugates Market (2nd Edition) by Type of Drug Conjugate, Type of Targeting Ligand, Type of Payload, Route of Administration, Type of Therapy, Therapeutic Area, Geographical Regions, and Sales Forecast - Trends and Forecast, Till 2035 - Product Thumbnail Image

Next Generation Drug Conjugates Market (2nd Edition) by Type of Drug Conjugate, Type of Targeting Ligand, Type of Payload, Route of Administration, Type of Therapy, Therapeutic Area, Geographical Regions, and Sales Forecast - Trends and Forecast, Till 2035

  • Report
  • July 2026
  • 266 Pages
  • Global
From
Colorectal Cancer Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Colorectal Cancer Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 198 Pages
  • Global
From
Cardiovascular Collaboration and Licensing Deals 2016-2026 - Product Thumbnail Image

Cardiovascular Collaboration and Licensing Deals 2016-2026

  • Report
  • October 2026
  • 350 Pages
  • Global
From
Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Regional Outlook and Forecast, 2022 - 2028 - Product Thumbnail Image

Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Regional Outlook and Forecast, 2022 - 2028

  • Report
  • November 2022
  • 175 Pages
  • Global
From
Unresectable Hepatocellular Carcinoma Market Report 2026 - Product Thumbnail Image

Unresectable Hepatocellular Carcinoma Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Rheumatoid Arthritis Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Rheumatoid Arthritis Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • Report
  • February 2024
  • 91 Pages
  • Global
From
ADC Contract Manufacturing Market (7th Edition): Distribution by Stage of Development, Process Component, Type of Payload, Antibody Isotype, Target Indication, Antibody Origin, Type of Linker, and Key Geographical Regions - Industry Trends and Forecast 2025-2035 - Product Thumbnail Image

ADC Contract Manufacturing Market (7th Edition): Distribution by Stage of Development, Process Component, Type of Payload, Antibody Isotype, Target Indication, Antibody Origin, Type of Linker, and Key Geographical Regions - Industry Trends and Forecast 2025-2035

  • Report
  • March 2026
  • 451 Pages
  • Global
From
Mitoxantrone Hydrochloride Market - Global Forecast 2026-2032 - Product Thumbnail Image

Mitoxantrone Hydrochloride Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 180 Pages
  • Global
From
Rare Autoinflammatory Diseases Drug Market - Global Forecast 2026-2032 - Product Thumbnail Image

Rare Autoinflammatory Diseases Drug Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 187 Pages
  • Global
From
CD19 Target Drug Market - Global Forecast 2026-2032 - Product Thumbnail Image

CD19 Target Drug Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 185 Pages
  • Global
From
Single-target Anti-VEGF Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Single-target Anti-VEGF Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 190 Pages
  • Global
From
Graves' Ophthalmopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Graves' Ophthalmopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 67 Pages
  • Global
From
Age Related Macular Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Age Related Macular Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 289 Pages
  • Global
From
Loading Indicator